Example of Seminars in Hematology format
Recent searches

Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format Example of Seminars in Hematology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access ISSN: 371963 e-ISSN: 15328686

Seminars in Hematology — Template for authors

Publisher: Elsevier
Categories Rank Trend in last 3 yrs
Hematology #17 of 123 up up by 5 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 130 Published Papers | 931 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 10/06/2020
Insights & related journals
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Journal Performance & Insights

  • Impact Factor
  • CiteRatio
  • SJR
  • SNIP

Impact factor determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

4.379

17% from 2018

Impact factor for Seminars in Hematology from 2016 - 2019
Year Value
2019 4.379
2018 3.738
2017 3.926
2016 4.042
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 17% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

CiteRatio is a measure of average citations received per peer-reviewed paper published in the journal.

7.2

1% from 2019

CiteRatio for Seminars in Hematology from 2016 - 2020
Year Value
2020 7.2
2019 7.1
2018 8.0
2017 7.2
2016 5.9
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 1% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR) measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

1.638

13% from 2019

SJR for Seminars in Hematology from 2016 - 2020
Year Value
2020 1.638
2019 1.885
2018 2.165
2017 1.965
2016 1.688
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has decreased by 13% in last years.
  • This journal’s SJR is in the top 10 percentile category.

Source Normalized Impact per Paper (SNIP) measures actual citations received relative to citations expected for the journal's category.

0.997

3% from 2019

SNIP for Seminars in Hematology from 2016 - 2020
Year Value
2020 0.997
2019 0.971
2018 1.141
2017 1.109
2016 1.2
graph view Graph view
table view Table view

insights Insights

  • SNIP of this journal has increased by 3% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Related Journals

open access Open Access ISSN: 8876924 e-ISSN: 14765551
recommended Recommended

Nature

CiteRatio: 16.0 | SJR: 4.539 | SNIP: 2.28
open access Open Access ISSN: 13419625 e-ISSN: 14377772

Springer

CiteRatio: 4.6 | SJR: 1.06 | SNIP: 1.301
open access Open Access ISSN: 13570560 e-ISSN: 1559131X

Springer

CiteRatio: 6.3 | SJR: 1.037 | SNIP: 0.989
open access Open Access ISSN: 0268960X e-ISSN: 15321681
recommended Recommended

Elsevier

CiteRatio: 12.1 | SJR: 2.67 | SNIP: 2.494
Seminars in Hematology

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Elsevier

Seminars in Hematology

Seminars in Hematology is a topical journal that focuses on subjects of current importance in clinical hematology and related fields. The journal is devoted to making the present status of such topics and the results of new investigations readily available to the practicing ph...... Read More

Hematology

Medicine

i
Last updated on
10 Jun 2020
i
ISSN
0037-1963
i
Impact Factor
High - 1.152
i
Open Access
No
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
elsarticle-num
i
Citation Type
Numbered
[25]
i
Bibliography Example
G. E. Blonder, M. Tinkham, T. M. Klapwijk, Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion, Phys. Rev. B 25 (7) (1982) 4515–4532. URL 10.1103/PhysRevB.25.4515

Top papers written in this journal

open accessOpen access Journal Article
Primary systemic amyloidosis : clinical and laboratory features in 474 cases
Robert A. Kyle1, Morie A. Gertz
01 Jan 1995 - Seminars in Hematology

Topics:

Primary systemic amyloidosis (80%)80% related to the paper, AL amyloidosis (71%)71% related to the paper, Amyloidosis (63%)63% related to the paper, Immunoglobulin Light-chain Amyloidosis (60%)60% related to the paper
1,089 Citations
open accessOpen access Journal Article
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.
Vogelzang Nj1, William Breitbart1, David Cella1, Curt Ga1, Groopman Je1, Horning Sj1, Itri Lm1, Johnson Dh1, Scherr Sl1, Portenoy Rk1
01 Jul 1997 - Seminars in Hematology

Abstract:

Although fatigue is the most common symptom reported by cancer patients and has serious adverse effects on quality of life, it remains poorly understood A survey was designed to characterize the epidemiology of cancer-related fatigue from the perspectives of the patient, primary caregiver, and oncologist A telephone survey in... Although fatigue is the most common symptom reported by cancer patients and has serious adverse effects on quality of life, it remains poorly understood A survey was designed to characterize the epidemiology of cancer-related fatigue from the perspectives of the patient, primary caregiver, and oncologist A telephone survey included 419 cancer patients recruited from 100,000 randomly selected households nationwide Patients provided access to 200 primary caregivers (usually family members) who were also interviewed by telephone In a separate mail survey, 197 of 600 randomly sampled oncologists (unrelated to the patients) responded to a questionnaire that assessed perceptions and attitudes concerning fatigue in cancer patients who had received chemotherapy or radiotherapy and their caregivers The median patient age was 65 years, and the principal cancer diagnoses were breast (females) and genitourinary (males) Fifty-nine percent of the patients had received chemotherapy, 63% radiation therapy, and 24% both; 20% of patients received their last treatment within 6 weeks, 31% within 7 weeks to 1 year, and 49% more than 1 year ago More than three quarters of patients (78%) experienced fatigue (defined as a general feeling of debilitating tiredness or loss of energy) during the course of their disease and treatment Thirty-two percent experienced fatigue daily, and 32% reported fatigue significantly affected their daily routines Caregivers reported observing fatigue in 86% of the index patients, and oncologists perceived that 76% of their patients experienced fatigue Although oncologists believed that pain adversely affected their patients to a greater degree than fatigue (61% v 37%), patients felt that fatigue adversely affected their daily lives more than pain (61% v 19%) Most oncologists (80%) believed fatigue is overlooked or undertreated, and most patients (74%) considered fatigue a symptom to be endured Fifty percent of patients did not discuss treatment options with their oncologists, and only 27% reported that their oncologists recommended any treatment for fatigue When used, treatments for fatigue were generally perceived by patients and caregivers to be successful These data confirm the high prevalence and adverse impact of cancer-related fatigue, although it is seldom discussed and infrequently treated For patients and oncologists, improving the quality of life of cancer patients requires a heightened awareness of fatigue, a better understanding of its impact, and improve communication and familiarity with interventions that can reduce its debilitating effects read more read less

Topics:

Cancer Fatigue (70%)70% related to the paper, Cancer-related fatigue (67%)67% related to the paper
771 Citations
open accessOpen access Journal Article
The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.
David Cella1
01 Jul 1997 - Seminars in Hematology

Abstract:

Anemia, frequently associated with cancer and cancer treatment, can use a variety of symptoms that diminish overall quality of life (QOL). Fatigue is the most commonly reported symptom among cancer patients and can significantly affect their daily lives. Using the Functional Assessment of Cancer Therapy-General (FACT-G) instr... Anemia, frequently associated with cancer and cancer treatment, can use a variety of symptoms that diminish overall quality of life (QOL). Fatigue is the most commonly reported symptom among cancer patients and can significantly affect their daily lives. Using the Functional Assessment of Cancer Therapy-General (FACT-G) instrument, which measures general QOL, as a core questionnaire, 20 new questions related to the impact of fatigue and other anemia-related symptoms on patients with cancer were developed. Two new instruments were produced: the FACT-Fatigue (FACT-F), consisting of the FACT-G plus 13 fatigue items (the Fatigue Subscale), and the FACT-Anemia (FACT-An), consisting of the FACT-F plus seven items addressing other concerns related to anemia, but unrelated to fatigue. FACT-F and FACT-An demonstrated good stability (r = .87 for both) and strong internal consistency (alpha = .95 and .96, respectively). Test-retest reliability coefficients for the Fatigue Subscale and nonfatigue items also showed good stability (r = .84 to .90), and the Fatigue Subscale showed strong internal consistency (alpha = .93 to .95). Convergent and discriminant validity testing revealed a significantly positive relationship with other known measures of fatigue, a significant negative relationship with vigor, and an anticipated lack of relationship with social desirability. The FACT-An, FACT-F, and Fatigue Subscale were found to successfully discriminate patients based on hemoglobin (Hb) level and Eastern Cooperative Oncology Group (ECOG) performance status. When patients were divided into two groups by Hb levels, patients with Hb levels greater than 12 g/dL reported significantly less fatigue, fewer nonfatigue anemia symptoms, better physical well-being, better functional well-being, and higher general QOL. The FACT-An, the FACT-F, and the Fatigue Subscale are useful measures of QOL in cancer patients and add focus to the widespread clinical problems of anemia and fatigue. read more read less

Topics:

Quality of life (51%)51% related to the paper, Anemia (51%)51% related to the paper
626 Citations
open accessOpen access Journal Article DOI: 10.5555/URI:PII:0037196375900013
Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes.
01 Apr 1975 - Seminars in Hematology

Abstract:

Microorganisms ingested by PMNs are exposed to a variety of antimicrobial systems. Together they comprise a formidable armamentarium, and few organisms survive. The predominant antimicrobial system would be expected to vary with the species, the availability of oxygen and the type of microorganism ingested. There is considera... Microorganisms ingested by PMNs are exposed to a variety of antimicrobial systems. Together they comprise a formidable armamentarium, and few organisms survive. The predominant antimicrobial system would be expected to vary with the species, the availability of oxygen and the type of microorganism ingested. There is considerable evidence that the MPO-mediated antimicrobial system plays an important role in the destruction of certain microorganisms in most species; chicken heterophils, however, do not contain MPO,40 and some microorganisms are resistant to this system due to the nature of their cell wall material.146 Further, microbial catalase may offer some protection. The granulocytes of some species (e.g., rabbit, chicken) are rich in cationic proteins and these agents may play a particularly important role in these cells. Granular cationic proteins are less plentiful in human cells.111 Organisms vary in their susceptibility to lysozyme and this enzyme is absent from bovine leukocytes.113 It is probable that the total microbicidal potential of the leukocyte is in excess of its needs under most circumstances. This "overkill" capacity is a reflection of both the level of activity of individual systems and their variety. Particular organisms are susceptible to more than one antimicrobial system and thus may be effectively handled by back-up systems when one is absent. Thus, an organism normally killed by the peroxidase system may be handled less efficiently but adequately when MPO is absent by other oxygen-dependent antimicrobial systems. When a defect in oxidative metabolixm is present as in CGD, both MPO-catalyzed and nonenzymatic oxygen-dependent systems are absent. The ingested organism can, in some instances, supply the needed product of oxidative metabolism (i.e., H2O2); in other instances, oxygen-independent antimicrobial systems are adequate to prevent microbial growth. However, in yet other instances, the organisms survive and multiply and severe infection results. read more read less

Topics:

Antimicrobial (55%)55% related to the paper
590 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Seminars in Hematology.

It automatically formats your research paper to Elsevier formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Seminars in Hematology format uses elsarticle-num citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

Absolutely not! With our tool, you can freely write without having to focus on LaTeX. You can write your entire paper as per the Seminars in Hematology guidelines and autoformat it.

Yes. The template is fully compliant as per the guidelines of this journal. Our experts at SciSpace ensure that. Also, if there's any update in the journal format guidelines, we take care of it and include that in our algorithm.

Sure. We support all the top citation styles like APA style, MLA style, Vancouver style, Harvard style, Chicago style, etc. For example, in case of this journal, when you write your paper and hit autoformat, it will automatically update your article as per the Seminars in Hematology citation style.

You can avail our Free Trial for 7 days. I'm sure you'll find our features very helpful. Plus, it's quite inexpensive.

Yup. You can choose the right template, copy-paste the contents from the word doc and click on auto-format. You'll have a publish-ready paper that you can download at the end.

A matter of seconds. Besides that, our intuitive editor saves a load of your time in writing and formating your manuscript.

One little Google search can get you the Word template for any journal. However, why do you need a Word template when you can write your entire manuscript on SciSpace, autoformat it as per Seminars in Hematology's guidelines and download the same in Word, PDF and LaTeX formats? Try us out!.

Absolutely! You can do it using our intuitive editor. It's very easy. If you need help, you can always contact our support team.

SciSpace is an online tool for now. We'll soon release a desktop version. You can also request (or upvote) any feature that you think might be helpful for you and the research community in the feature request section once you sign-up with us.

Sure. You can request any template and we'll have it up and running within a matter of 3 working days. You can find the request box in the Journal Gallery on the right sidebar under the heading, "Couldn't find the format you were looking for?".

After you have written and autoformatted your paper, you can download it in multiple formats, viz., PDF, Docx and LaTeX.

To be honest, the answer is NO. The impact factor is one of the many elements that determine the quality of a journal. Few of those factors the review board, rejection rates, frequency of inclusion in indexes, Eigenfactor, etc. You must assess all the factors and then take the final call.

SHERPA/RoMEO Database

We have extracted this data from Sherpa Romeo to help our researchers understand the access level of this journal. The following table indicates the level of access a journal has as per Sherpa Romeo Archiving Policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

The 5 most common citation types in order of usage are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

Our journal submission experts are skilled in submitting papers to various international journals.

After uploading your paper on SciSpace, you would see a button to request a journal submission service for Seminars in Hematology.

Each submission service is completed within 4 - 5 working days.

Yes. SciSpace provides this functionality.

After signing up, you would need to import your existing references from Word or .bib file.

SciSpace would allow download of your references in Seminars in Hematology Endnote style, according to elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Seminars in Hematology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template